Whalegun
Home

Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/01/03

Trade details

Type
Insider sale
Amount
$314,413.68
Shares · price
5,768 sh · $54.51 a share
Held after
86,783 sh
Stock
Janux Therapeutics JANX
Person
Andrew Hollman MeyerChief Business Officer
Trade date
25/01/02
Filed
25/01/03
Days to filing
1 days

Sold 6.2% of holdings

Share of holding sold
6.2%

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/03~25/02/01

Andrew Hollman Meyer's recent trades

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $28.2K

    Filed 04/13

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $2.6M

    Filed 01/26

  • Andrew Hollman Meyer

    Planned saleJanux Therapeutics

    $1.7M

    Filed 01/23

  • Andrew Hollman Meyer

    SellJanux Therapeutics

    $25.8K

    Filed 01/02

  • Andrew Hollman Meyer

    Sell10b5-1 planJanux Therapeutics

    $88.7K

    Filed 25/12/03